XCOPRI — SK LIFE, approved 2025-08-18 (NDA212839).
10,243 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.